Latest clinical trials News | Page 13

Bionomics reports topline results in PREVAIL study of BNC210
Positive CHMP Opinion Etranacogene Dezaparvovec
$84 million boost to create more opportunities for medical research
NIH funds antibiotic trial for HIV and emphysema
Covid vaccine safety report – 15-12-2022
How can we meet needs of older adults with epilepsy?
Gene therapy offers hope for severe epilepsy
Illegal drug regulation in Australia: ‘It’s almost unethical not to revisit this’
Scientists propose system redesign to improve access to clinical trials
Medicare Sessions for Psychologists to Increase from 10 to 20
CSL’s Novel Gene Therapy HEMGENIX Demonstrates Durable Protection and Sustained Factor IX Activity Levels for People Living
Novotech awarded Asia Pacific CRO of Year 2022 for ‘Best Practices in Clinical Trials’
Enhertu achieved statistically significant overall survival, reducing risk of death by 36% vs. trastuzumab emtansine
Deakin and Barwon Health partner in new centre for disease research
Research recommendations to prevent limb amputation
Pre-clinical data for Kazia Therapeutics’ EVT801 published in cancer journal
AstraZeneca showcases strength of haematology portfolio and pipeline across multiple hard-to-treat conditions
Therapeutic Products Bill introduced
Why autistic children are more likely to have gut problems
Mater Research Showcase shines light on 2022 achievements
Analysis of impact of antivirals
Positive media coverage of cannabis studies regardless of therapeutic effect
COVID nasal sprays may one day prevent and treat infection
World’s first algae-based local anaesthetic another step closer to reality
We’re told to ‘eat a rainbow’ of fruit and vegetables
CSL secures US approval for breakthrough one-time haemophilia gene therapy
Honourable Anna Bligh AC joins forces with Griffith University to fight malaria
MND research goes global
Schizophrenia research led by UNSW academics receives $3m in NSW Health grants
Hope in Sight Community Forum 2022
U.S. Food and Drug Administration approves CSL’s HEMGENIX , first gene therapy for hemophilia B
IND approval from US FDA for theranostic SARBombesin trial in prostate cancer
Phase 2 trial of ChulaCov19 BNA159 mRNA Vaccine to start in Australia
AusBiotech Policy Forum: Biotech leaders head to Parliament
NSW new $4 million to improve schizophrenia treatment
WHO to identify pathogens that could cause future outbreaks and pandemics
Pancreas models may save life
Australian-first project to map people living with Huntington’s Disease
Jennie Mackenzie donates 20 million to Charles Perkins Centre
Telix acquires US radiochemistry business Optimal Tracers
ATAGI recommendations on use of Pfizer bivalent Covid vaccine
Long serving CSIRO Chief Executive Dr Larry Marshall to conclude third and final term June 2023
Budget support for biomanufacturing in Queensland
Women who have suffered health complications associated with Essure contraceptive device urged to register for Slater and Gordon
Australian doctors lead world-first cancer trial to treat rare leukaemia
AstraZeneca expands global footprint in rare disease with availability of first Alexion rare disease therapy for patients
Balloon labour induction safer for babies, Melbourne researchers find
Year-to-date and Q3 2022 results